Home/NeuroKappa Therapeutics/Lei Fang, Esq, MD, PhD

LF

Lei Fang, Esq, MD, PhD

Legal Counsel

NeuroKappa Therapeutics

Therapeutic Areas

Stroke Pain Management Addiction Therapy Depression

NeuroKappa Therapeutics Pipeline

Drug	Indication	Phase
Salvinorin A Novel Analog	Stroke (Neuroprotection)	Pre-clinical
Dezocine & Associated Products	Opioid Addiction Management / Pain	Pre-clinical

Leadership Team at NeuroKappa Therapeutics

Peter Fang, MD, MS

Renyu Liu, MD, PhD

John Grothusen, PhD

CSO (Chief Scientific Officer)

Gordon Barr, PhD

DMD (likely Director of Medicinal Chemistry)

Yi-yen Chen, PhD

Business Development

View full NeuroKappa Therapeutics profile